DK105811C - Fremgangsmåde til fremstilling af lysinorotat. - Google Patents

Fremgangsmåde til fremstilling af lysinorotat.

Info

Publication number
DK105811C
DK105811C DK312061AA DK312061A DK105811C DK 105811 C DK105811 C DK 105811C DK 312061A A DK312061A A DK 312061AA DK 312061 A DK312061 A DK 312061A DK 105811 C DK105811 C DK 105811C
Authority
DK
Denmark
Prior art keywords
preparation
lysine orotate
orotate
lysine
Prior art date
Application number
DK312061AA
Other languages
English (en)
Original Assignee
Aec Chim Organ Biolog
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aec Chim Organ Biolog filed Critical Aec Chim Organ Biolog
Application granted granted Critical
Publication of DK105811C publication Critical patent/DK105811C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK312061AA 1960-07-29 1961-07-28 Fremgangsmåde til fremstilling af lysinorotat. DK105811C (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR834523A FR88M (da) 1960-07-29 1960-07-29

Publications (1)

Publication Number Publication Date
DK105811C true DK105811C (da) 1966-11-14

Family

ID=8736588

Family Applications (1)

Application Number Title Priority Date Filing Date
DK312061AA DK105811C (da) 1960-07-29 1961-07-28 Fremgangsmåde til fremstilling af lysinorotat.

Country Status (7)

Country Link
US (1) US3161565A (da)
BE (1) BE606638A (da)
CH (1) CH394216A (da)
DK (1) DK105811C (da)
ES (1) ES269442A1 (da)
FR (1) FR88M (da)
GB (1) GB922361A (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3011437A1 (de) * 1980-03-25 1981-10-01 Hrvoje Dr. Zagreb Krnjevic Pharmazeutisches mittel zur heilung von entzuendlichen und/oder degenerativen und/oder atrophischen schleimhauterkrankungen
US5736531A (en) 1987-10-28 1998-04-07 Pro-Neuron, Inc. Compositions of chemotherapeutic agent or antiviral agent with acylated pyrimidine nucleosides
US5470838A (en) * 1987-10-28 1995-11-28 Pro-Neuron, Inc. Method of delivering exogenous uridine or cytidine using acylated uridine or cytidine
US7173017B1 (en) 1987-10-28 2007-02-06 Wellstat Therapeutics Corporation Pyrimidine nucleotide precursors for treatment of systemic inflammation and inflammatory hepatitis
US7776838B1 (en) 1987-10-28 2010-08-17 Wellstat Therapeutics Corporation Treatment of chemotherapeutic agent and antiviral agent toxicity with acylated pyrimidine nucleosides
CN101066276A (zh) * 1994-07-01 2007-11-07 威尔斯塔特医疗公司 用于治疗全身性炎症和炎性肝炎的嘧啶核苷酸前体

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2556907A (en) * 1950-01-27 1951-06-12 Du Pont Resolution of lysine
US2738299A (en) * 1953-05-11 1956-03-13 Abbott Lab Stable nutritive amino acid compositions
US2802864A (en) * 1953-09-01 1957-08-13 Int Minerals & Chem Corp Higher alkyl amine salts of glutamic acid
US2992163A (en) * 1955-11-07 1961-07-11 Lilly Co Eli Use of 4-chloro-1, 2-pyrazole for controlling epileptic seizures
US2859244A (en) * 1956-09-28 1958-11-04 Dow Chemical Co Resolution of dl-lysine with d-camphoric acid
US3020278A (en) * 1959-09-16 1962-02-06 Jr Edgar A Ferguson Vitamin-orotic acid compositions
US3062722A (en) * 1960-03-15 1962-11-06 Garofalo Domenico Therapeutic 2-aminoethanethiol orate

Also Published As

Publication number Publication date
CH394216A (fr) 1965-06-30
GB922361A (en) 1963-03-27
US3161565A (en) 1964-12-15
ES269442A1 (es) 1962-01-01
BE606638A (fr) 1961-11-16
FR88M (da) 1961-01-09

Similar Documents

Publication Publication Date Title
DK105811C (da) Fremgangsmåde til fremstilling af lysinorotat.
DK125082C (da) Analogifremgangsmåde til fremstilling af substituerede benzhydrylidencycloalkaner.
DK110096C (da) Fremgangsmåde til fremstilling af phenylcyclopropylamider.
DK110172C (da) Fremgangsmåde til fremstilling af 17α-klorætynyl-17β-hydroksysteroider.
DK104178C (da) Fremgangsmåde til fremstilling af asymmetriske nitrofurfuralaziner.
DK102868C (da) Fremgangsmåde til fremstilling af p-alkylbenzyl-tropin-derivater.
DK113287B (da) Fremgangsmåde ved fremstilling af manganoacetylacetonat.
DK98393C (da) Fremgangsmåde til fremstilling af tiakromonakridoner.
DK97291C (da) Fremgangsmåde til fremstilling af 6-chlor-benz-iso-thiazolon.
DK102525C (da) Fremgangsmåde til fremstilling af D-γ-galactonolactoner.
DK94264C (da) Fremgangsmåde til fremstilling af 2-hydroxymethylen-6-methoxytetralon.
DK96007C (da) Fremgangsmåde til fremstilling af kanamycin-3-phenylsalicylat.
DK102516C (da) Fremgangsmåde til fremstilling af α-methyl-5-hydroxy-tryptophan.
DK97645C (da) Fremgangsmåde til fremstilling af thiurammonosulfider.
DK96778C (da) Fremgangsmåde til fremstilling af 7-chlortetracyclin.
DK99140C (da) Fremgangsmåde til fremstilling af 17α-methyl-17-hydroxy-D-homosteroider.
DK104984C (da) Fremgangsmåde til fremstilling af 2-amino-3-methoxy-pyrazin.
DK97449C (da) Fremgangsmåde til fremstilling af 16α-methyl-21-acyloxy-18-nor-cortison.
DK99012C (da) Fremgangsmåde til fremstilling af 21-brom-5α- eller -5βpregnan-20-oner.
DK97933C (da) Fremgangsmåde til fremstilling af 7-chlor-6-demethyltetracyclin.
DK98300C (da) Fremgangsmåde til fremstilling af 2-sulfanilamido-3-methoxypyrazin.
DK97515C (da) Fremgangsmåde til fremstilling af 3-nitro-phenthiazin.
DK98956C (da) Fremgangsmåde til fremstilling af steroid-18-aldehyder.
DK102466C (da) Fremgangsmåde til fremstilling af 2-sulfanilamido-3-methoxypyrazin.
DK100169C (da) Fremgangsmåde til fremstilling af 2-β-metoksyætylpyridin.